RAP-103 [CAS 1337998-99-8]

RAP-103 is an orally active CCR antagonist that provides potent synaptic protection by inhibiting and reversing cytoskeletal changes induced by PrPC/NOX signaling. RAP-103 is potentially useful in Alzheimer's disease (AD) research[1].

[1337998-99-8]

C25H38N6O11

598.6

C[C@H](O)[C@H](C(O)=O)NC([C@@H](CC1=CC=C(O)C=C1)NC([C@@H](CC(N)=O)NC([C@@H]([C@@H](O)C)NC([C@@H]([C@@H](O)C)N)=O)=O)=O)=O

CCR

Room temperature